These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 2738671)

  • 1. Radiation dosimetry in radionuclide hysterosalpingography with technetium-99m.
    Stabin M
    J Nucl Med; 1989 Mar; 30(3):415-6. PubMed ID: 2738671
    [No Abstract]   [Full Text] [Related]  

  • 2. Radionuclide hysterosalpingography for evaluation of fallopian tube patency.
    McCalley MG; Braunstein P; Stone S; Henderson P; Egbert R
    J Nucl Med; 1985 Aug; 26(8):868-74. PubMed ID: 4032035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [About the possibility of fallopian tubes patency evaluations by means of 99mTc-pertechnetate and comparison of radiation loads due to radioisotopic and x-ray examinations (author's transl)].
    Rýznar V; Heczko P; Husák V; Gazárek F; Wiedermann M; Erban J; Pohanka J
    Cesk Gynekol; 1981 Nov; 46(9):692-5. PubMed ID: 6272998
    [No Abstract]   [Full Text] [Related]  

  • 4. Radiation exposure of the ovaries during hysterosalpingography. Is radionuclide hysterosalpingography justified?
    van der Weiden RM; van Zijl J
    Br J Obstet Gynaecol; 1989 Apr; 96(4):471-2. PubMed ID: 2751961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indication and clinical application of radionuclide hysterosalpingography using 99mTc-pertechnetate.
    Rýznar V; Heczko P; Husák V; Gazárek F; Pohanka J; Zenísek L; Wiedermann M; Erban J
    Acta Univ Palacki Olomuc Fac Med; 1984; 107():185-93. PubMed ID: 6100765
    [No Abstract]   [Full Text] [Related]  

  • 6. Technetium-99m hysterosalpingography in infertility: an accurate alternative to contrast hysterosalpingography.
    Angtuaco TL; Boyd CM; London SN; Powell LG; Diner WC; Vandergrift JF; Bersey ML; Bass BM; Donovan SA
    Radiographics; 1989 Jan; 9(1):115-28. PubMed ID: 2913615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation dosage of the ovaries during hysterosalpingography. Is radionuclide hysterosalpingography justified?
    Kennedy SH; Mojiminiyi OA; Soper ND; Shepstone BJ; Barlow DH
    Br J Obstet Gynaecol; 1989 Nov; 96(11):1359-60. PubMed ID: 2611179
    [No Abstract]   [Full Text] [Related]  

  • 8. Radionuclide hysterosalpingography with technetium-99m-pertechnetate: application and radiation dose to the ovaries.
    Yang KT; Chiang JH; Chen BS; Liang CH; Lee SF; Liao SC
    J Nucl Med; 1992 Feb; 33(2):282-6. PubMed ID: 1310106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Initial experiences with hysterosalpingoscintigraphy in normal and pathologic fallopian tube passage].
    Steck T; Becker W; Albert P; Börner W; Würfel W
    Geburtshilfe Frauenheilkd; 1989 Oct; 49(10):889-93. PubMed ID: 2583431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of radioisotope scanning for studying the fallopian tube functional state in women suffering from sterility].
    Pobedinskiĭ NM; Volobuev AI; Denisov PI; Chistiakova NA
    Akush Ginekol (Mosk); 1981 Feb; (2):14-7. PubMed ID: 6261599
    [No Abstract]   [Full Text] [Related]  

  • 11. Hysterosalpingoscintigraphy: a simple and accurate method of evaluating fallopian tube patency.
    Becker W; Steck T; Albert P; Börner W
    Nuklearmedizin; 1988 Dec; 27(6):252-7. PubMed ID: 3217255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the radionuclide hysterosalpingography].
    Sirandoni G; Villarroel C; Pastore U
    Rev Chil Obstet Ginecol; 1989; 54(3):124-8. PubMed ID: 2535229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hysterosalpingoscintigraphy.
    de Rossi G; Salvatori M; Giordano A; Romanini C; Dell'Acque S; Arduini D; Rizzo G
    Radiol Diagn (Berl); 1984; 25(5):573-6. PubMed ID: 6505207
    [No Abstract]   [Full Text] [Related]  

  • 14. [Radioisotope method for determination of patency of the fallopian tubes (author's transl)].
    Pertyński T; Jakubowski W; Stelmachów J; Graban W
    Pol Przegl Radiol Med Nukl; 1978; 42(2):145-8. PubMed ID: 704390
    [No Abstract]   [Full Text] [Related]  

  • 15. Hysterosalpingo-scintigraphy--some particular features.
    de Rossi G
    Radiol Diagn (Berl); 1987; 28(5):721-5. PubMed ID: 3423255
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hysterosalpingography in study of patency and therapy of obstruction of fallopian tubes; experience in 400 cases].
    ZANARTU J; HAMBLEN EC
    Ann Ostet Ginecol; 1953 Jun; 75(6):855-75. PubMed ID: 13125146
    [No Abstract]   [Full Text] [Related]  

  • 17. [Salpingography with thorotrast 23 years before development of ovarian carcinoma].
    SCHWENZER AW; FEDERLIN K
    Geburtshilfe Frauenheilkd; 1957 Mar; 17(3):225-36. PubMed ID: 13427974
    [No Abstract]   [Full Text] [Related]  

  • 18. Internal dosimetry of technetium-99m labelled radiopharmaceuticals used in clinical nuclear medicine.
    Roedler HD
    J Belge Radiol; 1977; 60(6):463-72. PubMed ID: 612670
    [No Abstract]   [Full Text] [Related]  

  • 19. [Nuclear-medical testing of retrograde tubal transport mechanism for sterility diagnosis (tubal isotope test TIT) (author's transl)].
    Link M; Otto HJ; Milbradt U
    Zentralbl Gynakol; 1980; 102(9):496-501. PubMed ID: 6258354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation absorbed dose from technetium-99m-labeled bone imaging agents. Task Group of the Medical Internal Radiation Dose Committee, The Society of Nuclear Medicine.
    Weber DA; Makler PT; Watson EE; Coffey JL; Thomas SR; London J
    J Nucl Med; 1989 Jun; 30(6):1117-22. PubMed ID: 2544697
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.